Farhad Khosravi
BioDirection, Inc., USA
Biography
Farhad Khosravi has expertise in applying nanotechnology to the development of in vitro diagnostic devices (IVD). His background in bioengineering and biomedical engineering in combination with his understanding of nanomaterials has enabled him to follow his passion for nanomedicine and nanodiagnostics. He first became interested in the intersection of nanomaterials and biosensors when completing his BS in Biomedical Engineering from the University of Louisville (UofL) where he first studied carbon nanotubes (CNT). During his doctoral work at Worcester Polytechnic Institute (WPI), he invented a novel CNT microarray biosensor platform for capture and detection of cancer cells. This research introduced a new philosophy for liquid biopsy useful for point-of-care diagnostics. Currently, Farhad is employed at BioDirection where he is developing silicon nanowire FET technology used in a biosensor platform for the detection of biomarkers associated with traumatic brain injury (TBI).
Abstract
Abstract : Development of silicon nanowire technology for biomarker testing